Lindsey Morris

Area Business Manager @Sanofi

Atlanta, GA, US

Successfully led the launch of Dupixent, the first FDA-approved treatment for both pediatric and adult patients with Eosinophilic Esophagitis (EoE), marking a significant advancement in care for this underserved patient population. Played a key role in driving market adoption through strategic targeting, clinical education, and collaboration with key stakeholders. Consistently exceeded both corporate and territory sales objectives quarter over quarter, establishing Dupixent as a market leader in the EoE space.

The University of Georgia

BS